LUPIN LTD. - The Company Plans To Carve Out, Its Trade Generics Business In India, As A Going Concern, On A Slump Sale Basis, To Lupin Life Sciences Limited, Wholly Owned Subsidiary Of The Company.
22 Mar 2024
The Company plans to carve out, its trade generics business in India, as a going concern, on a slump sale basis, to Lupin Life Sciences Limited, wholly owned subsidiary of the Company.
Source:
BSE India